Proven to reduce moderate-to-severe hot flashes: Evamist spray

A clinical study showed that Evamist significantly reduced the number and intensity of hot flashes in women experiencing menopause.¹ That may mean less time spent fanning yourself and stripping off layers and more time participating in your daily activities.

As with most estrogen therapies, you likely won’t feel better after only one dose of Evamist. Give it some time before reevaluating your symptoms. A clinical study showed that women felt over 50% fewer hot flashes within one month. On average, women felt increasingly better every week that they continued therapy in the 12-week study.²

Around-the-clock relief helps reduce hot flashes

Evamist delivers estrogen on a continuous basis over 24 hours.² When measuring the effects of medications, researchers monitor the levels of the medication in the bloodstream. The longer the medication stays at consistent levels in your bloodstream, the longer the medication is providing benefits.

Additionally, with Evamist, studies have shown that for an 8 AM dose, serum levels reach their peak between 2 AM and 6 AM.²

Not only does Evamist reduce your moderate-to-severe hot flashes, but it’s made from a plant-based source.² Find out more about what Evamist is made from.

» Footnote References

Important Safety Information

Evamist™ is approved by the FDA for use after menopause to reduce moderate-to-severe hot flashes.

Estrogens increase the chance of getting cancer of the uterus (womb). Report any unusual vaginal bleeding right away while you are using Evamist. Vaginal bleeding after menopause may be a warning sign of cancer of the uterus. Your healthcare provider should check any unusual vaginal bleeding to find out the cause.

Do not use estrogens with or without progestins to prevent heart disease, heart attacks, strokes, or dementia. Using estrogens, with or without progestins, may increase your chance of getting heart attacks, strokes, breast cancer, and blood clots. Using estrogen, with or without progestins, may increase your risk of dementia, based on a study of women age 65 years or older. Evamist should not be used if you have unusual vaginal bleeding; currently have or have had certain cancers, including cancer of the breast or uterus; had a stroke or heart attack in the past year; currently have or have had blood clots; currently have or have had liver problems; or think you may be, or know that you are, pregnant.

The most common side effects that may occur with Evamist are headache, breast tenderness, the common cold, nipple pain, back pain, nausea, and joint pain.

You and your healthcare provider should talk regularly about whether you still need treatment with Evamist.

Please see full prescribing information for Evamist.